droperidol has been researched along with dantrolene in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, G; Patel, P | 1 |
| Burke, C; Castellano, J; Fulda, GJ | 1 |
| Matthews, EE; Shaw, A | 1 |
| Cardinaud, JP; Favier, JC; Gbikpi-Benissan, G; Gruson, D; Hilbert, G; Portel, L | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Duncton, MA; Emerling, DE; Kelly, MG; Nguyen, MT; Vincent, F | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for droperidol and dantrolene
| Article | Year |
|---|---|
Neuroleptic malignant syndrome in a trauma patient.
Topics: Adult; Antipsychotic Agents; Dantrolene; Droperidol; Haloperidol; Humans; Male; Multiple Trauma; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychomotor Agitation | 1995 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for droperidol and dantrolene
| Article | Year |
|---|---|
Postoperative neuroleptic malignant syndrome. A case report.
Topics: Adult; Cryotherapy; Dantrolene; Droperidol; Humans; Male; Neuroleptic Malignant Syndrome; Postoperative Complications | 1987 |
Postoperative neuroleptic malignant syndrome.
Topics: Child; Dantrolene; Diuresis; Droperidol; Female; Humans; Hyponatremia; Metoclopramide; Neuroleptic Malignant Syndrome; Postoperative Complications | 1995 |
Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma.
Topics: Acute Disease; Adjuvants, Anesthesia; Adult; Anesthetics, Inhalation; Asthma; Bronchodilator Agents; Calcium Channel Blockers; Dantrolene; Droperidol; Glucocorticoids; Halothane; Humans; Intubation, Intratracheal; Magnesium Sulfate; Male; Malignant Hyperthermia; Methylprednisolone; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Respiration, Artificial; Rhabdomyolysis | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Topics: Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship | 2009 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |